Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02775422Terminated
Open-label, single-arm trial, sponsored by Hôpital Foch. Primary endpoint: Rate sensitivity and specificity in negative and dubious zone for the assessment of the serology of anti VZV immunity at 35 weeks. Started Mar 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02775422.